Polyamine structural effects on the induction and stabilization of liquid crystalline DNA: potential applications to DNA packaging, gene therapy and polyamine therapeutics.
DNA undergoes condensation, conformational transitions, aggregation and resolubilization in the presence of polyamines, positively charged organic molecules present in all cells. Under carefully controlled environmental conditions, DNA can also transform to a liquid crystalline state in vitro. We undertook the present work to examine the ability of spermidine, N4-methylspermidine, spermine, N1-acetylspermine and a group of tetramine, pentamine and hexamine analogs of spermine to induce and stabilize liquid crystalline DNA. Liquid crystalline textures were identified under a polarizing microscope. In the absence of polyamines, calf thymus DNA assumed a diffused, planar cholesteric phase with entrapped bubbles when incubated on a glass slide at 37 degrees C. In the presence of spermidine and spermine, the characteristic fingerprint textures of the cholesteric phase, adopting a hexagonal order, were obtained. The helical pitch was 2.5 micro m. The final structures were dendrimeric and crystalline when DNA was treated with spermine homologs and bis(ethyl) derivatives. A cholesteric structure was observed when DNA was treated with a hexamine at 37 degrees C. This structure changed to a hexagonal dendrimer with fluidity on prolonged incubation. These data show a structural specificity effect of polyamines on liquid crystalline phase transitions of DNA and suggest a possible physiological function of natural polyamines.
Department of Medicine, University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, New Brunswick, NJ 08903, USA.
M
M
Saminathan
Thresia
T
Thomas
Akira
A
Shirahata
C K S
CK
Pillai
T J
TJ
Thomas
D000818:Animals; D002417:Cattle; D003460:Crystallization; D004247:DNA / Q000737:chemistry* / Q000378:metabolism; D015316:Genetic Therapy / Q000379:methods; D008709:Methenamine / Q000737:chemistry / Q000494:pharmacology; D008859:Microscopy, Polarization; D009690:Nucleic Acid Conformation / Q000187:drug effects; D011073:Polyamines / Q000737:chemistry* / Q000494:pharmacology / Q000627:therapeutic use; D013095:Spermidine / Q000031:analogs & derivatives* / Q000737:chemistry / Q000494:pharmacology; D013096:Spermine / Q000031:analogs & derivatives* / Q000737:chemistry / Q000494:pharmacology; D013329:Structure-Activity Relationship; D013950:Thymus Gland / Q000378:metabolism
D011073:Polyamines; C073193:1-methylspermidine; C029452:N'-acetylspermine; D013096:Spermine; D004247:DNA; D008709:Methenamine; D013095:Spermidine